Using a personalized measure (Patient Generated Index (PGI)) to identify what matters to people with cancer

被引:23
作者
Aburub, Ala' S. [1 ]
Gagnon, B. [2 ]
Rodriguez, A. M. [3 ]
Mayo, Nancy E. [4 ]
机构
[1] McGill Univ, Div Clin Epidemiol, Sch Phys & Occupat Therapy, Montreal, PQ H3A 1A1, Canada
[2] Univ Laval, Ctr Rech CHU Quebec, Ctr Rech Canc, Dept Med Familiale & Med Urgence, Quebec City, PQ G1R 2J6, Canada
[3] McGill Univ, Sch Rehabil Sci, Montreal, PQ H3G 1Y5, Canada
[4] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada
关键词
Personalized measure; The Patient Generated Index; Quality of life; Generic measure; Cancer-specific measure; QUALITY-OF-LIFE; HEALTH UTILITIES; SLEEP DISORDERS; QUESTIONNAIRE; VALIDITY; SURVIVORS; CARE; VALIDATION; INSTRUMENT; ONCOLOGY;
D O I
10.1007/s00520-015-2821-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Patient Generated Index (PGI) is designed to both ask and document quality of life (QOL) concerns. Its validity with respect to standard QOL measures has not been fully established for advanced cancer when QOL concerns predominate. The specific objective of this study is to identify, for people with advanced cancer, similarities and differences in ratings of global QOL between personalized and standard measures. A total of 192 patients completed five QOL measures at study entry: PGI, generic measures (SF-6D, EQ-5D), and cancer-specific measures of QOL (McGill Quality of Life Questionnaire and Edmonton Symptoms Assessment Scale). Comparisons among total scores were compared using Generalized Estimating Equations (GEE). Patients voiced 114 areas of QOL concerns by the PGI with the top three being fatigue, sleep, and pain (39.2, 22.6, and 21.6 %, respectively). PGI total QOL score was 25 to 30 percentage points lower than those documented by the other measures, particularly when QOL was poor. Correlations between PGI and other measures were low. PGI allowed patients to express a wide range of QOL concerns, many that were not assessed by other QOL measures. If only one QOL measure is to be included, either in a clinical setting or for research, the PGI would satisfy many of the criteria for "best choice." PGI could be considered a cancer-specific QOL measure. This study provides evidence that the PGI would be a good measure for patients and clinicians to use together to identify areas of concern that require attention and monitor changing needs.
引用
收藏
页码:437 / 445
页数:9
相关论文
共 64 条
  • [21] Work ability and return-to-work in cancer patients
    de Boer, A. G. E. M.
    Verbeek, J. H. A. M.
    Spelten, E. R.
    Uitterhoeve, A. L. J.
    Ansink, A. C.
    de Reijke, T. M.
    Kammeijer, M.
    Sprangers, M. A. G.
    van Dijk, F. J. H.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 98 (08) : 1342 - 1347
  • [22] Survivorship: Sleep Disorders, Version 1.2014
    Den Linger, Crystal S.
    Ligibel, Jennifer A.
    Are, Madhuri
    Baker, K. Scott
    Demark-Wahnefried, Wendy
    Friedman, Debra L.
    Goldman, Mindy
    Jones, Lee
    King, Allison
    Ku, Grace H.
    Kvale, Elizabeth
    Langbaum, Terry S.
    Leonardi-Warren, Kristin
    McCabe, Mary S.
    Melisko, Michelle
    Montoya, Jose G.
    Mooney, Kathi
    Morgan, Mary Ann
    Moslehi, Javid J.
    O'Connor, Tracey
    Overholser, Linda
    Paskett, Electra D.
    Raza, Muhammad
    Syrjala, Karen L.
    Urba, Susan G.
    Wakabayashi, Mark T.
    Zee, Phyllis
    McMillian, Nicole
    Freedman-Cass, Deborah
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (05): : 630 - 642
  • [23] Sleep-wake disturbances in cancer patients: narrative review of literature focusing on improving quality of life outcomes
    Dickerson, Suzanne S.
    Connors, Laurie M.
    Fayad, Ameera
    Dean, Grace E.
    [J]. NATURE AND SCIENCE OF SLEEP, 2014, 6 : 85 - 100
  • [24] Modeling valuations for EuroQol health states
    Dolan, P
    [J]. MEDICAL CARE, 1997, 35 (11) : 1095 - 1108
  • [25] Whose preferences count?
    Dolan, P
    [J]. MEDICAL DECISION MAKING, 1999, 19 (04) : 482 - 486
  • [26] Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: a cross-sectional study in a community hospital outpatient centre
    Frick, E.
    Tyroller, M.
    Panzer, M.
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2007, 16 (02) : 130 - 136
  • [27] A qualitative evaluation of the validity of published health utilities and generic health utility measures for capturing health-related quality of life (HRQL) impact of differentiated thyroid cancer (DTC) at different treatment phases
    Gallop, Katy
    Kerr, Cicely
    Simmons, Stacey
    McIver, Bryan
    Cohen, Ezra E. W.
    [J]. QUALITY OF LIFE RESEARCH, 2015, 24 (02) : 325 - 338
  • [28] Quality of life measurement: bibliographic study of patient assessed health outcome measures
    Garratt, AN
    Schmidt, L
    Mackintosh, A
    Fitzpatrick, R
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2002, 324 (7351): : 1417 - 1419
  • [29] Pain in Cancer Survivors
    Glare, Paul A.
    Davies, Pamela S.
    Finlay, Esme
    Gulati, Amitabh
    Lemanne, Dawn
    Moryl, Natalie
    Oeffinger, Kevin C.
    Paice, Judith A.
    Stubblefield, Michael D.
    Syrjala, Karen L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (16) : 1739 - 1747
  • [30] Empirical criteria for the selection of quality-of-life instruments for the evaluation of peripheral blood progenitor cell transplantation
    Glick, HA
    Shpall, EJ
    LeMaistre, CF
    McCarron, TJ
    Lu, ZJ
    Erder, MH
    Glaspy, JA
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1998, 14 (03) : 419 - 430